Tag: genomics
-
Gene Therapy Designed for Muscle Wasting Disease
Researchers devised a treatment for a cancer-related muscle wasting disease using gene transfers that in lab mice block signals promoting muscle degradation.
-
Common Antibodies Found for Multi-Virus Flu Vaccine
A team at National Institutes of Health discovered three types of antibodies that can neutralize a variety of influenza viral strains infecting humans.
-
Genetic Disease Biotech Gains $55M in Early Funds
A biotechnology start-up developing therapies for genetic diseases through regulation of genetic processes is raising $55 million in its first venture round.
-
23andMe Offering Genetic Analysis Service for Researchers
23andMe is offering a new analytical service for researchers that determines genotypes, or genetic variations, of individuals taking part in their studies.
-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.
-
New Leukemia Target, Drug Candidate Discovered
An industry-academic research team identified a new target for acute myeloid leukemia, and tested a new drug that stops the growth of these cancer cells.
-
RNA Technology Allows for Fast Vaccine Development
Engineers at MIT designed a process using genetic material in nanoscale particles for vaccines that protected against dangerous diseases with a single dose.
-
Moderna, Merck Partner on Personal Cancer Vaccines
29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 million, and the chance to earn further payments to develop cancer treatments combining Moderna’s technology with an…
-
Animal-Free Leather Company Gains $40M in Venture Funds
A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round.